1) Adenovirus p53 Infected DC Vaccine For Breast Cancer, 2) Translation of Biotechnology Into the Clinic
Phase of Trial: Phase I/II
Latest Information Update: 19 Dec 2018
At a glance
- Drugs INGN 225 (Primary) ; Cyclophosphamide; Doxorubicin; Paclitaxel
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Nov 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 24 Oct 2017 Planned End Date changed from 1 Dec 2014 to 1 Apr 2019.